Cardiac Rehabilitation: From Hospital to Municipal Setting.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03734185 |
|
Recruitment Status :
Recruiting
First Posted : November 7, 2018
Last Update Posted : July 28, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Cardiac Rehabilitation | Other: Learning and Coping | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 1100 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Factorial Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Cardiac Rehabilitation: From Hospital to Municipal Setting. |
| Actual Study Start Date : | September 1, 2018 |
| Estimated Primary Completion Date : | July 31, 2020 |
| Estimated Study Completion Date : | June 30, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Learning and Coping
A health pedagogical strategy that builds on inductive teaching with high involvement of the participants. Characteristics of Learning and Coping are that 'experienced patients' plan, teach and evaluate, in cooperation with health professionals.
|
Other: Learning and Coping
'Experienced patients' plan, teach and evaluate, in cooperation with health professionals. |
|
Active Comparator: Usual Cardiac Rehabilitation
The theoretical frameworks used in some of these local healthcare services are empowerment, self-efficacy and self-management
|
Other: Learning and Coping
'Experienced patients' plan, teach and evaluate, in cooperation with health professionals. |
- Adherence [ Time Frame: At the end of a 12 week rehabilitation program ]Adherence is final CR assessment and discharge to long term management from primary health service. This information is obtained from the Central Denmark Region Cardiac Rehabilitation Database - recorded: yes/no
- Health-related quality of life [ Time Frame: 4 times during 12 months after engaging Cardia Rehabilitation ]Questionnaire; HearQol The HeartQol questionnaire assesses health-related quality of life; physical and emotional condition. The HeartQoL questionnaire was first described in the literature in 2012. It is a 14-item assessment and evaluation system specific to IHD that assesses the impact of cardiac intervention on patient-reported health-related quality of life. HeartQoL consists of two subscales, a 10-item physical subscale and a 4-item emotional subscale. Scores range from 0 to 3 with higher scores indicating a better health-related quality of life. The HeartQol questionnaire has been validated in Danish patients with heart valve surgery.
- Anxiety and depression [ Time Frame: 4 times during 12 months after engaging Cardia Rehabilitation ]Questionnaire; HADS Hospital Anxiety and Depression Scale assesses states of depression and anxiety in the setting of an hospital medical outpatient clinic and primary care population. The scale consist of 14 items - seven concerning anxiety and seven concerning depression An analysis of scores on the two subscales of a further sample, in the same clinical setting, showed that a score of 0 to 7 for either subscale could be regarded as being in the normal range, a score of 11 or higher indicating probable presence ('caseness') of the mood disorder and a score of 8 to 10 being just suggestive of the presence of the respective state. The Hospital Anxiety and Depression Scale is a valid and reliable instrument that has been used across the world in cardiac and non-cardiac populations.
- Coping [ Time Frame: 4 times during 12 months after engaging Cardia Rehabilitation ]Questionnaire; PAM The Patient Activation Measure assesses the patients' activation level in four elements; knowledge, skills, confidence and behaviours. The scale consists of 13-items. The Patient Activation Measure identifies four different levels of activation. The Patient Activation Measure is a valid and reliable instrument that has been used across the world in populations with chronic diseases. The Patient Activation Measure is translated and validated in Danish setting.
- Return to work [ Time Frame: 12 months after ended Cardiac Rehabilitation ]Sick leave and work disability are registered in the Danish Register for Evaluation of Marginalisation (DREAM). DREAM includes all Danish citizens who have received social benefits or any other public benefits since July 1991. Transfer benefits, which can be grouped into five categories: Benefits to otherwise self-supporting individuals, labor market-related benefits, temporary health-related benefits (sickness benefit and vocational rehabilitation benefit), permanent health-related benefits (partial and full disability pension), and benefits related to old age or early retirement. If no transfer income is registered for a specific week, the person is considered to be self-supporting or on short-term sick-leave (less than 2 weeks). In Denmark, a citizen in the workforce (employed as well as unemployed) is entitled to sickness absence compensation, and in case the employee receives normal salary during sick leave, the employer receives a municipal reimbursement.
- Cost-effectiveness [ Time Frame: When patients enter intervention CR or usual CR and again 12 months after ended CR ]EQ-5D assesses health related quality of life and practical for economic evaluation. Patients are asked to complete the questionnaire at baseline and 12 months after the completed CR. EQ-5D was first introduced in 1990 by the EuroQol Group. The EQ-5D has been extensively used to assess patient utility in trials of new treatments. The index-based score is generated by applying societal preference weights to the health state classification completed by the patient that consists of five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), each with three levels of response or severity (no problems, some problems, or extreme problems). The ability to convert self classification responses into a single index score makes the EQ-5D practical for clinical and economic evaluation.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion criteria:
We include all adult patients ( >18 years old) discharged from hospital with in Central Denmark Region between September 1, 2018 and July 31, 2019. Ischaemic Heart Disease will be defined according to the International Classification of Diseases version 10 (ICD-10): DI210, DI210A, DI210B, DI211, DI211A, DI211B, DI213, DI214, DI219, DI248, DI249, DI240, DI209, DI251, DI251B, and DI251. In 2016, this population represented approx. 2,700 patients.
Exclusion criteria:
People survive cardiac arrest
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03734185
| Contact: Charlotte Gjørup Pedersen, PhD | 0045 21656160 | chgjpe@rm.dk | |
| Contact: Inger Hornbech | 0045 4028 8134 | inghor@rm.dk |
| Denmark | |
| Charlotte Gjørup Pedersen | Recruiting |
| Aarhus, Denmark, 8000 | |
| Contact: Charlotte Pedersen, PhD 0045 21656160 chgjpe@rm.dk | |
| Contact: Inger Hornbech 0045 4028 8134 inghor@rm.dk | |
| Principal Investigator: | Charlotte Gjørup Pedersen, PhD | Defactum, Central Denmark Region |
| Responsible Party: | Charlotte Gjørup Pedersen, PostDoc, PhD, MHSc, Defactum, Central Denmark Region |
| ClinicalTrials.gov Identifier: | NCT03734185 |
| Other Study ID Numbers: |
Cardiac Rehab |
| First Posted: | November 7, 2018 Key Record Dates |
| Last Update Posted: | July 28, 2020 |
| Last Verified: | July 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cardiac Rehabilitation |

